The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...
Research led by Professor Hai-Ling Margaret Cheng (BME) opens the door to earlier treatment and better outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback